Terms: = Colorectal cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR
307 results:
1. Tissue-resident memory CD103+CD8+ T cells in colorectal cancer: its implication as a prognostic and predictive liver metastasis biomarker.
Liu S; Wang P; Wang P; Zhao Z; Zhang X; Pan Y; Pan J
Cancer Immunol Immunother; 2024 Jul; 73(9):176. PubMed ID: 38954030
[TBL] [Abstract] [Full Text] [Related]
2. [Advances of car-T cell therapy in treating colorectal cancer].
Chao Z; Liu W; Liu Y
Sheng Wu Gong Cheng Xue Bao; 2024 May; 40(5):1365-1379. PubMed ID: 38783803
[TBL] [Abstract] [Full Text] [Related]
3. A novel LAG3 neutralizing antibody improves cancer immunotherapy by dual inhibition of MHC-II and FGL1 ligand binding.
Zuo D; Zhu Y; Wang K; Qin Y; Su Y; Lan S; Li Y; Dong S; Liang Y; Feng M
Biomed Pharmacother; 2024 Jun; 175():116782. PubMed ID: 38776682
[TBL] [Abstract] [Full Text] [Related]
4. Safety and biological outcomes following a phase 1 trial of GD2-specific car-T cells in patients with GD2-positive metastatic melanoma and other solid cancers.
Gargett T; Truong NTH; Gardam B; Yu W; Ebert LM; Johnson A; Yeo ECF; Wittwer NL; Tapia Rico G; Logan J; Sivaloganathan P; Collis M; Ruszkiewicz A; Brown MP
J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754916
[TBL] [Abstract] [Full Text] [Related]
5. Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses.
Tapia-Galisteo A; Sánchez-Rodríguez I; Narbona J; Iglesias-Hernández P; Aragón-García S; Jiménez-Reinoso A; Compte M; Khan S; Tsuda T; Chames P; Lacadena J; Álvarez-Vallina L; Sanz L
Oncoimmunology; 2024; 13(1):2338558. PubMed ID: 38623463
[TBL] [Abstract] [Full Text] [Related]
6. B7-H3 Expression in Breast cancer and Brain Metastasis.
Joshi V; Beecher K; Lim M; Stacey A; Feng Y; Jat PS; Duijf PHG; Simpson PT; Lakhani SR; McCart Reed AE
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612786
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study.
Ercan AB; Aronson M; Fernandez NR; Chang Y; Levine A; Liu ZA; Negm L; Edwards M; Bianchi V; Stengs L; Chung J; Al-Battashi A; Reschke A; Lion A; Ahmad A; Lassaletta A; Reddy AT; Al-Darraji AF; Shah AC; Van Damme A; Bendel A; Rashid A; Margol AS; Kelly BL; Pencheva B; Heald B; Lemieux-Anglin B; Crooks B; Koschmann C; Gilpin C; Porter CC; Gass D; Samuel D; Ziegler DS; Blumenthal DT; Kuo DJ; Hamideh D; Basel D; Khuong-Quang DA; Stearns D; Opocher E; Carceller F; Baris Feldman H; Toledano H; Winer I; Scheers I; Fedorakova I; Su JM; Vengoechea J; Sterba J; Knipstein J; Hansford JR; Gonzales-Santos JR; Bhatia K; Bielamowicz KJ; Minhas K; Nichols KE; Cole KA; Penney L; Hjort MA; Sabel M; Gil-da-Costa MJ; Murray MJ; Miller M; Blundell ML; Massimino M; Al-Hussaini M; Al-Jadiry MF; Comito MA; Osborn M; Link MP; Zapotocky M; Ghalibafian M; Shaheen N; Mushtaq N; Waespe N; Hijiya N; Fuentes-Bolanos N; Ahmad O; Chamdine O; Roy P; Pichurin PN; Nyman P; Pearlman R; Auer RC; Sukumaran RK; Kebudi R; Dvir R; Raphael R; Elhasid R; McGee RB; Chami R; Noss R; Tanaka R; Raskin S; Sen S; Lindhorst S; Perreault S; Caspi S; Riaz S; Constantini S; Albert S; Chaleff S; Bielack S; Chiaravalli S; Cramer SL; Roy S; Cahn S; Penna S; Hamid SA; Ghafoor T; Imam U; Larouche V; Magimairajan Issai V; Foulkes WD; Lee YY; Nathan PC; Maruvka YE; Greer MC; Durno C; Shlien A; Ertl-Wagner B; Villani A; Malkin D; Hawkins C; Bouffet E; Das A; Tabori U
Lancet Oncol; 2024 May; 25(5):668-682. PubMed ID: 38552658
[TBL] [Abstract] [Full Text] [Related]
8. Redefining the battle against colorectal cancer: a comprehensive review of emerging immunotherapies and their clinical efficacy.
Shebbo S; Binothman N; Darwaish M; Niaz HA; Abdulal RH; Borjac J; Hashem AM; Mahmoud AB
Front Immunol; 2024; 15():1350208. PubMed ID: 38533510
[TBL] [Abstract] [Full Text] [Related]
9. Building a Better Defense: Expanding and Improving Natural Killer Cells for Adoptive Cell Therapy.
Maia A; Tarannum M; Lérias JR; Piccinelli S; Borrego LM; Maeurer M; Romee R; Castillo-Martin M
Cells; 2024 Mar; 13(5):. PubMed ID: 38474415
[TBL] [Abstract] [Full Text] [Related]
10. IL-15-secreting car natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts.
Van den Eynde A; Gehrcken L; Verhezen T; Lau HW; Hermans C; Lambrechts H; Flieswasser T; Quatannens D; Roex G; Zwaenepoel K; Marcq E; Joye P; Cardenas De La Hoz E; Deben C; Gasparini A; Montay-Gruel P; Le Compte M; Lion E; Lardon F; Van Laere S; Siozopoulou V; Campillo-Davo D; De Waele J; Pauwels P; Jacobs J; Smits E; Van Audenaerde JRM
J Hematol Oncol; 2024 Feb; 17(1):8. PubMed ID: 38331849
[TBL] [Abstract] [Full Text] [Related]
11. Novel immunotherapies for breast cancer: Focus on 2023 findings.
Lan HR; Chen M; Yao SY; Chen JX; Jin KT
Int Immunopharmacol; 2024 Feb; 128():111549. PubMed ID: 38266449
[TBL] [Abstract] [Full Text] [Related]
12. New immunotherapy approaches for colorectal cancer: focusing on car-T cell, BiTE, and oncolytic viruses.
Kamrani A; Nasiri H; Hassanzadeh A; Ahmadian Heris J; Mohammadinasab R; Sadeghvand S; Sadeghi M; Valedkarimi Z; Hosseinzadeh R; Shomali N; Akbari M
Cell Commun Signal; 2024 Jan; 22(1):56. PubMed ID: 38243252
[TBL] [Abstract] [Full Text] [Related]
13. Regulation of the colon-targeted release rate of lactoferrin by constructing hydrophobic ethyl cellulose/pectin composite nanofibrous carrier and its effect on anti-colon cancer activity.
Wei YS; Feng K; Wu H
Int J Biol Macromol; 2024 Mar; 261(Pt 1):129466. PubMed ID: 38242414
[TBL] [Abstract] [Full Text] [Related]
14. The combined detection of hematological indicators is used for the differential diagnosis of colorectal cancer and benign-colorectal lesions.
Zhang X; Wu YY; Qin YY; Lin FQ
Cancer Biomark; 2024; 39(3):223-230. PubMed ID: 38217586
[TBL] [Abstract] [Full Text] [Related]
15. Exploring preventive care practices among unvaccinated individuals in the United States during the COVID-19 pandemic.
Filipas DK; Labban M; Beatrici E; Stone BV; Qian Z; D Andrea V; Ludwig TA; Reis LO; Cole AP; Trinh QD
Vaccine; 2024 Jan; 42(3):441-447. PubMed ID: 38184391
[TBL] [Abstract] [Full Text] [Related]
16. Targeting colorectal cancer cells using AND-gated adaptor Revcar T-cells.
Soto KEG; Loureiro LR; Bartsch T; Arndt C; Kegler A; Mitwasi N; Drewitz L; Hoffmann L; Saleh HA; Crespo E; Mehnert M; Daglar C; Abken H; Momburg F; Bachmann M; Feldmann A
Front Immunol; 2023; 14():1302354. PubMed ID: 38169746
[TBL] [Abstract] [Full Text] [Related]
17. Unraveling the multifaceted role of EpCAM in colorectal cancer: an integrated review of its function and interplay with non-coding RNAs.
Jiang X; Wang S; Liang Q; Liu Y; Liu L
Med Oncol; 2023 Dec; 41(1):35. PubMed ID: 38151631
[TBL] [Abstract] [Full Text] [Related]
18. Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing.
Juraske C; Krissmer SM; Teuber ES; Parigiani MA; Strietz J; Wesch D; Kabelitz D; Minguet S; Schamel WW
J Leukoc Biol; 2024 Jan; 115(2):293-305. PubMed ID: 38149982
[TBL] [Abstract] [Full Text] [Related]
19. Cumulative Absolute Risk of Subsequent colorectal cancer After Abdominopelvic Radiotherapy Among Childhood cancer Survivors: A PancareSurFup Study.
Heymer EJ; Jóźwiak K; Kremer LC; Winter DL; de Vathaire F; Sunguc C; Sugden E; Kok JL; van der Pal HJH; Hjorth L; Jakab Z; Maule MM; Haupt R; Bagnasco F; Terenziani M; Diallo I; Gunnes MW; Sommer G; Zadravec Zaletel L; Kuehni CE; Winther JF; Lähteenmäki PM; Gudmundsdottir T; Allodji RS; Skinner R; Ronckers CM; Hawkins MM; Reulen RC; Teepen JC
J Clin Oncol; 2024 Jan; 42(3):336-347. PubMed ID: 37972325
[TBL] [Abstract] [Full Text] [Related]
20. Implications of single-cell immune landscape of tumor microenvironment for the colorectal cancer diagnostics and therapy.
Alzamami A
Med Oncol; 2023 Nov; 40(12):352. PubMed ID: 37950801
[TBL] [Abstract] [Full Text] [Related]
[Next]
